Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
< b > Conditions < /b > : Neoplasm Metastasis; Sarcoma; Neoplasms, Germ Cell and Embryonal; Melanoma < br/ > < b > Interventions < /b > : Drug: decitabine (DAC); Drug: Tetrahydrouridine (THU); Drug: Celecoxib < br/ > < b > Sponsor < /b > : National Cancer Institute (NCI) < br/ > < b > Recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Celebrex | Embryonal Carcinoma | Melanoma | Oral Cancer | Research | Sarcomas | Skin Cancer